

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.62860924 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.62860924 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.29988149 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.29988149 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.84636992 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.45712508 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.16228909 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.16228909 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.16228909 |
| 10 | intestinal cholesterol absorption (GO:0030299) | 6.05539806 |
| 11 | kynurenine metabolic process (GO:0070189) | 6.03369357 |
| 12 | regulation of plasminogen activation (GO:0010755) | 5.97453076 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.96124609 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.80585342 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.80255125 |
| 16 | urea cycle (GO:0000050) | 5.68790598 |
| 17 | urea metabolic process (GO:0019627) | 5.68790598 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.68622766 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.66447626 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.61385355 |
| 21 | regulation of fibrinolysis (GO:0051917) | 5.45401397 |
| 22 | protein carboxylation (GO:0018214) | 5.40743386 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.40743386 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.36349254 |
| 25 | cysteine metabolic process (GO:0006534) | 5.34480139 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.32484457 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.30380069 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.23172216 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 5.13978918 |
| 30 | bile acid metabolic process (GO:0008206) | 5.09989890 |
| 31 | protein-lipid complex subunit organization (GO:0071825) | 5.03970573 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 4.98892149 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.97774714 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.94400679 |
| 35 | regulation of complement activation (GO:0030449) | 4.94054619 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.91668750 |
| 37 | regulation of apoptotic cell clearance (GO:2000425) | 4.90750940 |
| 38 | epoxygenase P450 pathway (GO:0019373) | 4.89169993 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.85192890 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.85192890 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.85192890 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.84773414 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.84654203 |
| 44 | negative regulation of protein activation cascade (GO:2000258) | 4.81218668 |
| 45 | exogenous drug catabolic process (GO:0042738) | 4.76996907 |
| 46 | homocysteine metabolic process (GO:0050667) | 4.73894866 |
| 47 | acute-phase response (GO:0006953) | 4.72644120 |
| 48 | phospholipid efflux (GO:0033700) | 4.67911233 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.66787006 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.66787006 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.66399296 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.66399296 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 4.65228514 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 4.59439485 |
| 55 | lysine catabolic process (GO:0006554) | 4.55877421 |
| 56 | lysine metabolic process (GO:0006553) | 4.55877421 |
| 57 | negative regulation of hemostasis (GO:1900047) | 4.53456396 |
| 58 | negative regulation of blood coagulation (GO:0030195) | 4.53456396 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 4.48096527 |
| 60 | regulation of humoral immune response (GO:0002920) | 4.43714984 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 4.43513891 |
| 62 | glycine metabolic process (GO:0006544) | 4.42484790 |
| 63 | coenzyme catabolic process (GO:0009109) | 4.41213866 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.39445346 |
| 65 | indolalkylamine metabolic process (GO:0006586) | 4.36808734 |
| 66 | imidazole-containing compound metabolic process (GO:0052803) | 4.35589223 |
| 67 | amine catabolic process (GO:0009310) | 4.27812008 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 4.27812008 |
| 69 | cholesterol efflux (GO:0033344) | 4.27502657 |
| 70 | cellular amino acid catabolic process (GO:0009063) | 4.27473629 |
| 71 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.27269271 |
| 72 | positive regulation of hemostasis (GO:1900048) | 4.26789432 |
| 73 | positive regulation of blood coagulation (GO:0030194) | 4.26789432 |
| 74 | cellular glucuronidation (GO:0052695) | 4.25446521 |
| 75 | glutamate metabolic process (GO:0006536) | 4.24424605 |
| 76 | omega-hydroxylase P450 pathway (GO:0097267) | 4.22069490 |
| 77 | serine family amino acid metabolic process (GO:0009069) | 4.17167442 |
| 78 | negative regulation of coagulation (GO:0050819) | 4.14247811 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 4.13421620 |
| 80 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.13359343 |
| 81 | ethanol oxidation (GO:0006069) | 4.07456153 |
| 82 | arginine metabolic process (GO:0006525) | 4.06242754 |
| 83 | cellular modified amino acid catabolic process (GO:0042219) | 4.05057690 |
| 84 | plasma lipoprotein particle assembly (GO:0034377) | 4.04286221 |
| 85 | proline metabolic process (GO:0006560) | 4.04230403 |
| 86 | low-density lipoprotein particle remodeling (GO:0034374) | 4.03893983 |
| 87 | fibrinolysis (GO:0042730) | 4.03603064 |
| 88 | aldehyde catabolic process (GO:0046185) | 4.03192330 |
| 89 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02943728 |
| 90 | serine family amino acid biosynthetic process (GO:0009070) | 4.00768517 |
| 91 | negative regulation of wound healing (GO:0061045) | 3.99382153 |
| 92 | drug catabolic process (GO:0042737) | 3.93866143 |
| 93 | cholesterol transport (GO:0030301) | 3.91694157 |
| 94 | sterol transport (GO:0015918) | 3.91694157 |
| 95 | lipoprotein metabolic process (GO:0042157) | 3.90579311 |
| 96 | ketone body metabolic process (GO:1902224) | 3.87958024 |
| 97 | negative regulation of complement activation (GO:0045916) | 3.87956224 |
| 98 | positive regulation of coagulation (GO:0050820) | 3.87794029 |
| 99 | blood coagulation, intrinsic pathway (GO:0007597) | 3.87214556 |
| 100 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.86059511 |
| 101 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.86059511 |
| 102 | negative regulation of lipase activity (GO:0060192) | 3.83636408 |
| 103 | cofactor catabolic process (GO:0051187) | 3.81845825 |
| 104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.78029315 |
| 105 | intestinal absorption (GO:0050892) | 3.77936035 |
| 106 | positive regulation of lipid catabolic process (GO:0050996) | 3.77791695 |
| 107 | glucuronate metabolic process (GO:0019585) | 3.77427948 |
| 108 | uronic acid metabolic process (GO:0006063) | 3.77427948 |
| 109 | complement activation, classical pathway (GO:0006958) | 3.76819080 |
| 110 | peptidyl-glutamic acid modification (GO:0018200) | 3.75346651 |
| 111 | cholesterol homeostasis (GO:0042632) | 3.75118079 |
| 112 | organic acid catabolic process (GO:0016054) | 3.73847191 |
| 113 | carboxylic acid catabolic process (GO:0046395) | 3.73847191 |
| 114 | complement activation (GO:0006956) | 3.72609230 |
| 115 | protein activation cascade (GO:0072376) | 3.72125520 |
| 116 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71278738 |
| 117 | phospholipid homeostasis (GO:0055091) | 3.71122130 |
| 118 | sterol homeostasis (GO:0055092) | 3.68861355 |
| 119 | ethanol metabolic process (GO:0006067) | 3.68490303 |
| 120 | plasma lipoprotein particle organization (GO:0071827) | 3.67344166 |
| 121 | short-chain fatty acid metabolic process (GO:0046459) | 3.64872791 |
| 122 | cytolysis (GO:0019835) | 3.64790841 |
| 123 | acetyl-CoA metabolic process (GO:0006084) | 3.64616773 |
| 124 | protein-lipid complex assembly (GO:0065005) | 3.62236685 |
| 125 | regulation of cholesterol homeostasis (GO:2000188) | 3.61196474 |
| 126 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.59166417 |
| 127 | acute inflammatory response (GO:0002526) | 3.58665708 |
| 128 | NAD biosynthetic process (GO:0009435) | 3.56780364 |
| 129 | opsonization (GO:0008228) | 3.54646459 |
| 130 | drug metabolic process (GO:0017144) | 3.48773559 |
| 131 | regulation of lipoprotein particle clearance (GO:0010984) | 3.46158791 |
| 132 | diacylglycerol metabolic process (GO:0046339) | 3.39330136 |
| 133 | positive regulation of steroid metabolic process (GO:0045940) | 3.38252967 |
| 134 | lipid homeostasis (GO:0055088) | 3.26360017 |
| 135 | oxidative demethylation (GO:0070989) | 3.23900130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.41186189 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.22051931 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.05087026 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51039411 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.32583299 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.15434792 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.88826581 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.04788594 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.02983033 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.60755340 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.10819665 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07809865 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.05315078 |
| 14 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9521968 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98501842 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.97979476 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59861102 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57377616 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54092522 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41644724 |
| 21 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39337581 |
| 22 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.32458314 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30372722 |
| 24 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20534159 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18087823 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16686330 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.16199486 |
| 28 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.08335051 |
| 29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07683095 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06072141 |
| 31 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04001843 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03000890 |
| 33 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02715185 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00637669 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95529852 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91122222 |
| 37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90859220 |
| 38 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.90432035 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90306362 |
| 40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85603044 |
| 41 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.85091676 |
| 42 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84275189 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84261705 |
| 44 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84062328 |
| 45 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.83447940 |
| 46 | ERA_21632823_ChIP-Seq_H3396_Human | 0.82750594 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82489496 |
| 48 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.80797095 |
| 49 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.80150216 |
| 50 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80057422 |
| 51 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79350421 |
| 52 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.78310695 |
| 53 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.77691821 |
| 54 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.77628564 |
| 55 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77463829 |
| 56 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77287540 |
| 57 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.76703923 |
| 58 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76315890 |
| 59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.76028525 |
| 60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75123991 |
| 61 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74893065 |
| 62 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.74701344 |
| 63 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.74555714 |
| 64 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74182266 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71540386 |
| 66 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71142550 |
| 67 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.71101261 |
| 68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70809140 |
| 69 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.70150613 |
| 70 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.68348238 |
| 71 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66578367 |
| 72 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66553073 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66400384 |
| 74 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.65388797 |
| 75 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.64537031 |
| 76 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.64301840 |
| 77 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64193654 |
| 78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63547761 |
| 79 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63516190 |
| 80 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.63394020 |
| 81 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.62846782 |
| 82 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61817639 |
| 83 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.61617681 |
| 84 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.60716528 |
| 85 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.60275236 |
| 86 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.60246522 |
| 87 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.60246522 |
| 88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60222761 |
| 89 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.60158211 |
| 90 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.60155956 |
| 91 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59890931 |
| 92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.58565592 |
| 93 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.58263132 |
| 94 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57495796 |
| 95 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.57138650 |
| 96 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.57138650 |
| 97 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.56816765 |
| 98 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.55237529 |
| 99 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.54709010 |
| 100 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.54674668 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54612414 |
| 102 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54405934 |
| 103 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.54209379 |
| 104 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.53520467 |
| 105 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53244418 |
| 106 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52329439 |
| 107 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52056477 |
| 108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51656744 |
| 109 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51573314 |
| 110 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51143732 |
| 111 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49301626 |
| 112 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48947329 |
| 113 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47879549 |
| 114 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47253566 |
| 115 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46988023 |
| 116 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45782241 |
| 117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44291874 |
| 118 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43505090 |
| 119 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43217669 |
| 120 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.43112074 |
| 121 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.43060891 |
| 122 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42501299 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41521667 |
| 124 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.41494862 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41102676 |
| 126 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40264762 |
| 127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40228863 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39557545 |
| 129 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.39044103 |
| 130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38749990 |
| 131 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.38715771 |
| 132 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.38654968 |
| 133 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38150648 |
| 134 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38124571 |
| 135 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.37482342 |
| 136 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.36821964 |
| 137 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36022453 |
| 138 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35338364 |
| 139 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34587391 |
| 140 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34350199 |
| 141 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33949647 |
| 142 | * LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.33937924 |
| 143 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.33342316 |
| 144 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.33244556 |
| 145 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.32831505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.37148946 |
| 2 | MP0005360_urolithiasis | 7.51597581 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.45784549 |
| 4 | MP0005365_abnormal_bile_salt | 6.19156887 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.18224096 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.24331384 |
| 7 | MP0003252_abnormal_bile_duct | 3.90203518 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.60569193 |
| 9 | MP0003122_maternal_imprinting | 3.55379505 |
| 10 | MP0009840_abnormal_foam_cell | 3.36565459 |
| 11 | MP0005083_abnormal_biliary_tract | 3.05537074 |
| 12 | MP0003195_calcinosis | 2.87257111 |
| 13 | MP0005332_abnormal_amino_acid | 2.75767409 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.58776393 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.36884135 |
| 16 | * MP0000609_abnormal_liver_physiology | 2.13245435 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.12887076 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.10766440 |
| 19 | MP0000566_synostosis | 2.09546370 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.96236525 |
| 21 | MP0003868_abnormal_feces_composition | 1.93572281 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.82600584 |
| 23 | MP0001764_abnormal_homeostasis | 1.67606702 |
| 24 | MP0009697_abnormal_copulation | 1.60920713 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56945962 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.54367177 |
| 27 | MP0002089_abnormal_postnatal_growth/wei | 1.49384263 |
| 28 | MP0005451_abnormal_body_composition | 1.49372439 |
| 29 | MP0003123_paternal_imprinting | 1.43260092 |
| 30 | MP0003011_delayed_dark_adaptation | 1.41775693 |
| 31 | MP0003186_abnormal_redox_activity | 1.26563232 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.26484842 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.21852438 |
| 34 | MP0000598_abnormal_liver_morphology | 1.17481136 |
| 35 | MP0001915_intracranial_hemorrhage | 1.16421514 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.14965145 |
| 37 | MP0005647_abnormal_sex_gland | 1.14125440 |
| 38 | MP0005167_abnormal_blood-brain_barrier | 1.10203559 |
| 39 | MP0000604_amyloidosis | 1.09933695 |
| 40 | MP0003121_genomic_imprinting | 1.08210368 |
| 41 | MP0009764_decreased_sensitivity_to | 1.06440590 |
| 42 | MP0005377_hearing/vestibular/ear_phenot | 1.02465255 |
| 43 | MP0003878_abnormal_ear_physiology | 1.02465255 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.01759778 |
| 45 | MP0002254_reproductive_system_inflammat | 0.99996075 |
| 46 | MP0006292_abnormal_olfactory_placode | 0.97891718 |
| 47 | * MP0009763_increased_sensitivity_to | 0.96957347 |
| 48 | MP0010368_abnormal_lymphatic_system | 0.96656683 |
| 49 | MP0005636_abnormal_mineral_homeostasis | 0.91389782 |
| 50 | MP0005410_abnormal_fertilization | 0.91279589 |
| 51 | MP0008469_abnormal_protein_level | 0.88547285 |
| 52 | * MP0009642_abnormal_blood_homeostasis | 0.86022718 |
| 53 | MP0003879_abnormal_hair_cell | 0.84361222 |
| 54 | MP0005408_hypopigmentation | 0.83648187 |
| 55 | MP0006036_abnormal_mitochondrial_physio | 0.82077644 |
| 56 | MP0005376_homeostasis/metabolism_phenot | 0.79948551 |
| 57 | MP0003567_abnormal_fetal_cardiomyocyte | 0.79277113 |
| 58 | MP0009765_abnormal_xenobiotic_induced | 0.78491245 |
| 59 | MP0005670_abnormal_white_adipose | 0.77887312 |
| 60 | MP0002876_abnormal_thyroid_physiology | 0.77369199 |
| 61 | MP0002078_abnormal_glucose_homeostasis | 0.77193985 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 0.76631537 |
| 63 | MP0005084_abnormal_gallbladder_morpholo | 0.73871846 |
| 64 | MP0002938_white_spotting | 0.73112094 |
| 65 | MP0002282_abnormal_trachea_morphology | 0.72022663 |
| 66 | MP0002971_abnormal_brown_adipose | 0.71261295 |
| 67 | MP0005220_abnormal_exocrine_pancreas | 0.70504660 |
| 68 | MP0003690_abnormal_glial_cell | 0.68534458 |
| 69 | MP0005334_abnormal_fat_pad | 0.68328732 |
| 70 | MP0004130_abnormal_muscle_cell | 0.67493904 |
| 71 | MP0009053_abnormal_anal_canal | 0.66566504 |
| 72 | MP0005535_abnormal_body_temperature | 0.66454954 |
| 73 | MP0001661_extended_life_span | 0.65471867 |
| 74 | MP0005266_abnormal_metabolism | 0.64672674 |
| 75 | MP0002909_abnormal_adrenal_gland | 0.63796067 |
| 76 | MP0003329_amyloid_beta_deposits | 0.63278211 |
| 77 | MP0000639_abnormal_adrenal_gland | 0.61669042 |
| 78 | MP0009780_abnormal_chondrocyte_physiolo | 0.58327931 |
| 79 | MP0005646_abnormal_pituitary_gland | 0.58303997 |
| 80 | MP0001756_abnormal_urination | 0.57613802 |
| 81 | MP0006035_abnormal_mitochondrial_morpho | 0.56374701 |
| 82 | MP0001324_abnormal_eye_pigmentation | 0.55457224 |
| 83 | MP0001529_abnormal_vocalization | 0.55395575 |
| 84 | MP0005448_abnormal_energy_balance | 0.54616502 |
| 85 | MP0005464_abnormal_platelet_physiology | 0.53197684 |
| 86 | MP0002822_catalepsy | 0.50901413 |
| 87 | MP0005379_endocrine/exocrine_gland_phen | 0.49955386 |
| 88 | MP0003632_abnormal_nervous_system | 0.49606782 |
| 89 | MP0005395_other_phenotype | 0.49027384 |
| 90 | MP0003638_abnormal_response/metabolism_ | 0.46592691 |
| 91 | MP0008874_decreased_physiological_sensi | 0.46554634 |
| 92 | MP0003718_maternal_effect | 0.46210786 |
| 93 | MP0008873_increased_physiological_sensi | 0.45194867 |
| 94 | MP0003633_abnormal_nervous_system | 0.44055219 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.43861579 |
| 96 | MP0006054_spinal_hemorrhage | 0.43854961 |
| 97 | MP0002928_abnormal_bile_duct | 0.43641947 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.42823257 |
| 99 | MP0003436_decreased_susceptibility_to | 0.41970375 |
| 100 | MP0002837_dystrophic_cardiac_calcinosis | 0.41726845 |
| 101 | MP0005248_abnormal_Harderian_gland | 0.41491542 |
| 102 | MP0003075_altered_response_to | 0.41087567 |
| 103 | MP0003631_nervous_system_phenotype | 0.40957301 |
| 104 | MP0003724_increased_susceptibility_to | 0.40948824 |
| 105 | MP0004043_abnormal_pH_regulation | 0.40769691 |
| 106 | MP0003943_abnormal_hepatobiliary_system | 0.40407456 |
| 107 | MP0003953_abnormal_hormone_level | 0.40376658 |
| 108 | MP0005257_abnormal_intraocular_pressure | 0.39009339 |
| 109 | MP0001270_distended_abdomen | 0.38965740 |
| 110 | MP0008872_abnormal_physiological_respon | 0.38631408 |
| 111 | MP0002249_abnormal_larynx_morphology | 0.38062513 |
| 112 | MP0005166_decreased_susceptibility_to | 0.38028913 |
| 113 | MP0004381_abnormal_hair_follicle | 0.37941800 |
| 114 | MP0002160_abnormal_reproductive_system | 0.37621688 |
| 115 | MP0001293_anophthalmia | 0.36333455 |
| 116 | MP0009672_abnormal_birth_weight | 0.36315569 |
| 117 | MP0005666_abnormal_adipose_tissue | 0.36311766 |
| 118 | MP0001986_abnormal_taste_sensitivity | 0.35438928 |
| 119 | MP0004742_abnormal_vestibular_system | 0.35129605 |
| 120 | MP0000920_abnormal_myelination | 0.35002278 |
| 121 | MP0000579_abnormal_nail_morphology | 0.34066629 |
| 122 | MP0005409_darkened_coat_color | 0.33961587 |
| 123 | MP0000249_abnormal_blood_vessel | 0.32876709 |
| 124 | MP0002796_impaired_skin_barrier | 0.32348699 |
| 125 | MP0004883_abnormal_blood_vessel | 0.32337798 |
| 126 | MP0009115_abnormal_fat_cell | 0.32335763 |
| 127 | MP0001243_abnormal_dermal_layer | 0.31852754 |
| 128 | MP0006082_CNS_inflammation | 0.31588297 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.31009765 |
| 130 | MP0002168_other_aberrant_phenotype | 0.30896536 |
| 131 | MP0009384_cardiac_valve_regurgitation | 0.29966236 |
| 132 | MP0002970_abnormal_white_adipose | 0.29933092 |
| 133 | MP0001853_heart_inflammation | 0.29851211 |
| 134 | MP0001881_abnormal_mammary_gland | 0.27627896 |
| 135 | MP0001845_abnormal_inflammatory_respons | 0.27496077 |
| 136 | MP0005164_abnormal_response_to | 0.25116079 |
| 137 | MP0002090_abnormal_vision | 0.24071796 |
| 138 | MP0002132_abnormal_respiratory_system | 0.23372652 |
| 139 | MP0002060_abnormal_skin_morphology | 0.23154906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.49515981 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.47166333 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.28155281 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.72962515 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.60910385 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.51715911 |
| 7 | Xanthomatosis (HP:0000991) | 6.30952627 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.72927690 |
| 9 | Complement deficiency (HP:0004431) | 5.33555140 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.86480646 |
| 11 | Joint hemorrhage (HP:0005261) | 4.82929758 |
| 12 | Hyperammonemia (HP:0001987) | 4.61942248 |
| 13 | Epidermoid cyst (HP:0200040) | 4.50930362 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.47861708 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.44774180 |
| 16 | Hyperglycinemia (HP:0002154) | 4.40126740 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.33812210 |
| 18 | Ketosis (HP:0001946) | 4.26701801 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26690393 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.26478351 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.14624626 |
| 22 | Fat malabsorption (HP:0002630) | 4.10016479 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.09751152 |
| 24 | Abnormality of complement system (HP:0005339) | 3.89224835 |
| 25 | Hyperglycinuria (HP:0003108) | 3.87997106 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.87549432 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.87549432 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.87064339 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.84581819 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.78061137 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.66278430 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.62374600 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.39450508 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.35093564 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.34089351 |
| 36 | Steatorrhea (HP:0002570) | 3.11318333 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.11157707 |
| 38 | Spontaneous abortion (HP:0005268) | 3.07513733 |
| 39 | Purpura (HP:0000979) | 3.06747538 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.06446696 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05740324 |
| 42 | Ketoacidosis (HP:0001993) | 2.98828799 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.98225737 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.97751363 |
| 45 | Myocardial infarction (HP:0001658) | 2.93496007 |
| 46 | Skin nodule (HP:0200036) | 2.77645518 |
| 47 | Metabolic acidosis (HP:0001942) | 2.77151768 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.71883972 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.65078317 |
| 50 | Lethargy (HP:0001254) | 2.61145466 |
| 51 | Vascular calcification (HP:0004934) | 2.58283108 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.58049154 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.58049154 |
| 54 | Acanthocytosis (HP:0001927) | 2.49095974 |
| 55 | Abnormal gallbladder morphology (HP:0012437) | 2.47702177 |
| 56 | Spastic diplegia (HP:0001264) | 2.46909153 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.45990926 |
| 58 | Arthropathy (HP:0003040) | 2.44782268 |
| 59 | Glomerulonephritis (HP:0000099) | 2.44396490 |
| 60 | Broad alveolar ridges (HP:0000187) | 2.44352943 |
| 61 | Cerebral edema (HP:0002181) | 2.43132069 |
| 62 | Mitral stenosis (HP:0001718) | 2.42162976 |
| 63 | Gout (HP:0001997) | 2.41925259 |
| 64 | Cholelithiasis (HP:0001081) | 2.41779630 |
| 65 | Cholecystitis (HP:0001082) | 2.39346584 |
| 66 | Abnormal gallbladder physiology (HP:0012438) | 2.39346584 |
| 67 | Osteomalacia (HP:0002749) | 2.38333363 |
| 68 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.36219563 |
| 69 | Neonatal onset (HP:0003623) | 2.35796289 |
| 70 | Irritability (HP:0000737) | 2.35538098 |
| 71 | Amyloidosis (HP:0011034) | 2.34695353 |
| 72 | Facial shape deformation (HP:0011334) | 2.32630315 |
| 73 | Potter facies (HP:0002009) | 2.32630315 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.31771197 |
| 75 | Cardiovascular calcification (HP:0011915) | 2.28927761 |
| 76 | Malnutrition (HP:0004395) | 2.25914991 |
| 77 | Increased serum pyruvate (HP:0003542) | 2.25586492 |
| 78 | Abnormality of carpal bone ossification (HP:0006257) | 2.24003012 |
| 79 | Gingival bleeding (HP:0000225) | 2.23411953 |
| 80 | Esophageal varix (HP:0002040) | 2.18933292 |
| 81 | Menorrhagia (HP:0000132) | 2.16869650 |
| 82 | Brushfield spots (HP:0001088) | 2.15856904 |
| 83 | Pulmonary embolism (HP:0002204) | 2.14818853 |
| 84 | Sensorimotor neuropathy (HP:0007141) | 2.14339050 |
| 85 | Pancreatitis (HP:0001733) | 2.13263591 |
| 86 | Late onset (HP:0003584) | 2.13008037 |
| 87 | Enlarged kidneys (HP:0000105) | 2.10701519 |
| 88 | Thrombophlebitis (HP:0004418) | 2.10101366 |
| 89 | Abnormal tarsal ossification (HP:0008369) | 2.08875581 |
| 90 | Vomiting (HP:0002013) | 2.06704869 |
| 91 | Vaginal fistula (HP:0004320) | 2.06476567 |
| 92 | Opisthotonus (HP:0002179) | 2.03113413 |
| 93 | Small epiphyses (HP:0010585) | 2.01234900 |
| 94 | Abnormality of the gallbladder (HP:0005264) | 2.01034684 |
| 95 | Generalized aminoaciduria (HP:0002909) | 2.00999784 |
| 96 | Abnormality of glycolysis (HP:0004366) | 2.00156919 |
| 97 | Hemorrhage of the eye (HP:0011885) | 1.99787668 |
| 98 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99473564 |
| 99 | Poikilocytosis (HP:0004447) | 1.99103582 |
| 100 | Hepatoblastoma (HP:0002884) | 1.95402326 |
| 101 | Rickets (HP:0002748) | 1.93432341 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 1.92821069 |
| 103 | Hypothermia (HP:0002045) | 1.91197599 |
| 104 | Widely patent fontanelles and sutures (HP:0004492) | 1.90550122 |
| 105 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88633922 |
| 106 | Abnormal cartilage morphology (HP:0002763) | 1.88390504 |
| 107 | Hypophosphatemic rickets (HP:0004912) | 1.87207409 |
| 108 | Retinal atrophy (HP:0001105) | 1.87165906 |
| 109 | Abnormality of the nasal septum (HP:0000419) | 1.85027543 |
| 110 | Renal cortical cysts (HP:0000803) | 1.84518371 |
| 111 | Hydroxyprolinuria (HP:0003080) | 1.81804075 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 1.81804075 |
| 113 | Bifid scrotum (HP:0000048) | 1.81426864 |
| 114 | Elevated hepatic transaminases (HP:0002910) | 1.81139088 |
| 115 | Status epilepticus (HP:0002133) | 1.80981547 |
| 116 | Alkalosis (HP:0001948) | 1.80435959 |
| 117 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78219977 |
| 118 | Abnormality of urine glucose concentration (HP:0011016) | 1.77734980 |
| 119 | Glycosuria (HP:0003076) | 1.77734980 |
| 120 | Pigmentary retinal degeneration (HP:0001146) | 1.76439372 |
| 121 | Nephritis (HP:0000123) | 1.73797982 |
| 122 | Reduced antithrombin III activity (HP:0001976) | 1.73688723 |
| 123 | Abnormality of vitamin metabolism (HP:0100508) | 1.73456285 |
| 124 | Hyperglycemia (HP:0003074) | 1.71171158 |
| 125 | Diastasis recti (HP:0001540) | 1.71019984 |
| 126 | Fair hair (HP:0002286) | 1.70916964 |
| 127 | Neoplasm of the liver (HP:0002896) | 1.67755429 |
| 128 | Gangrene (HP:0100758) | 1.66147094 |
| 129 | Abnormality of the vitreous humor (HP:0004327) | 1.63402697 |
| 130 | Joint swelling (HP:0001386) | 1.63077229 |
| 131 | Epiphyseal dysplasia (HP:0002656) | 1.62605993 |
| 132 | Abnormal hand bone ossification (HP:0010660) | 1.62216251 |
| 133 | Abnormality of the lumbar spine (HP:0100712) | 1.61988875 |
| 134 | Hyperphosphaturia (HP:0003109) | 1.61912609 |
| 135 | Abnormality of the Achilles tendon (HP:0005109) | 1.61834439 |
| 136 | Submucous cleft hard palate (HP:0000176) | 1.60992628 |
| 137 | Epistaxis (HP:0000421) | 1.59137757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.28008345 |
| 2 | FGFR4 | 4.63680531 |
| 3 | SIK1 | 4.56195609 |
| 4 | WNK4 | 4.46795690 |
| 5 | ERN1 | 4.44385509 |
| 6 | TAOK3 | 3.02758025 |
| 7 | INSRR | 2.89875594 |
| 8 | ERBB4 | 2.87039187 |
| 9 | TYRO3 | 2.51143452 |
| 10 | MAP2K4 | 2.38047253 |
| 11 | PKN2 | 2.30479101 |
| 12 | SIK2 | 2.22369685 |
| 13 | FGFR1 | 2.11237681 |
| 14 | MST1R | 2.07332532 |
| 15 | FLT3 | 1.96251577 |
| 16 | MAPK11 | 1.85775818 |
| 17 | PIK3CG | 1.83230231 |
| 18 | TRIB3 | 1.82018815 |
| 19 | NTRK3 | 1.73950816 |
| 20 | TYK2 | 1.69089347 |
| 21 | MAP4K2 | 1.65564973 |
| 22 | LATS1 | 1.62979985 |
| 23 | WNK1 | 1.59225819 |
| 24 | DAPK2 | 1.56878767 |
| 25 | ABL2 | 1.50121570 |
| 26 | PTK6 | 1.47234302 |
| 27 | CDK12 | 1.42395239 |
| 28 | NEK9 | 1.38409191 |
| 29 | FGFR2 | 1.37956880 |
| 30 | FRK | 1.37414441 |
| 31 | KDR | 1.32699653 |
| 32 | AKT3 | 1.29589711 |
| 33 | JAK2 | 1.21453815 |
| 34 | PINK1 | 1.18528718 |
| 35 | MAP3K7 | 1.18087254 |
| 36 | DDR2 | 1.10291208 |
| 37 | PRKAA2 | 1.10253161 |
| 38 | MAP2K3 | 1.09020471 |
| 39 | GRK6 | 1.08767964 |
| 40 | TBK1 | 1.08090386 |
| 41 | BCR | 1.03047383 |
| 42 | ERBB2 | 1.00037867 |
| 43 | MAPK4 | 0.99801529 |
| 44 | JAK1 | 0.99654059 |
| 45 | WNK3 | 0.95342548 |
| 46 | MAP3K14 | 0.95237848 |
| 47 | MAP3K10 | 0.95069655 |
| 48 | FGR | 0.93559521 |
| 49 | NTRK2 | 0.93230680 |
| 50 | PRKCZ | 0.92941914 |
| 51 | SGK1 | 0.89713563 |
| 52 | PDGFRA | 0.88987747 |
| 53 | MAPK15 | 0.87400983 |
| 54 | MAP3K3 | 0.86643117 |
| 55 | EPHB1 | 0.84613462 |
| 56 | CSNK1E | 0.84559521 |
| 57 | DYRK2 | 0.83929927 |
| 58 | STK38L | 0.83921950 |
| 59 | MET | 0.82879241 |
| 60 | CDK6 | 0.82298364 |
| 61 | MAPK12 | 0.82004421 |
| 62 | MAP3K11 | 0.80652548 |
| 63 | CDK7 | 0.79987631 |
| 64 | TIE1 | 0.79073632 |
| 65 | PRKACG | 0.76061308 |
| 66 | EPHA3 | 0.74851692 |
| 67 | CAMK2G | 0.73134887 |
| 68 | MAP2K6 | 0.71683005 |
| 69 | CASK | 0.70811423 |
| 70 | CSK | 0.70710836 |
| 71 | MAPKAPK3 | 0.70504945 |
| 72 | DYRK1B | 0.70269919 |
| 73 | MAP3K2 | 0.69072923 |
| 74 | CSNK1D | 0.67552142 |
| 75 | BMPR1B | 0.67425382 |
| 76 | GSK3A | 0.66982184 |
| 77 | EIF2AK1 | 0.66402010 |
| 78 | CAMK1D | 0.65195841 |
| 79 | PRKG1 | 0.63505359 |
| 80 | PRKAA1 | 0.63323914 |
| 81 | IRAK3 | 0.62055757 |
| 82 | MATK | 0.61821934 |
| 83 | SGK3 | 0.61033475 |
| 84 | RIPK1 | 0.60864296 |
| 85 | RPS6KB1 | 0.60021927 |
| 86 | ADRBK2 | 0.59911643 |
| 87 | MAPK7 | 0.58805210 |
| 88 | TGFBR2 | 0.57840824 |
| 89 | STK39 | 0.55954554 |
| 90 | PTK2 | 0.55749121 |
| 91 | IKBKE | 0.55197183 |
| 92 | FGFR3 | 0.55193922 |
| 93 | CSF1R | 0.55159250 |
| 94 | PRKCQ | 0.52131874 |
| 95 | PDPK1 | 0.52035699 |
| 96 | PRKACA | 0.50994845 |
| 97 | EPHA4 | 0.50757273 |
| 98 | CSNK1G1 | 0.50457716 |
| 99 | TAOK2 | 0.48658424 |
| 100 | NME1 | 0.45832219 |
| 101 | MARK1 | 0.44740018 |
| 102 | GRK1 | 0.44676331 |
| 103 | MAP3K5 | 0.44616155 |
| 104 | SGK2 | 0.43373045 |
| 105 | RET | 0.43135637 |
| 106 | MAP2K1 | 0.43122571 |
| 107 | IGF1R | 0.43099154 |
| 108 | PRKCG | 0.42196324 |
| 109 | CSNK2A1 | 0.41973738 |
| 110 | CSNK2A2 | 0.41790971 |
| 111 | MAP3K13 | 0.41066290 |
| 112 | CDK4 | 0.40715609 |
| 113 | CAMKK2 | 0.39694310 |
| 114 | RPS6KA3 | 0.38957055 |
| 115 | ICK | 0.38644635 |
| 116 | PKN1 | 0.37482513 |
| 117 | MAP3K6 | 0.37370513 |
| 118 | PBK | 0.37086803 |
| 119 | SRC | 0.36560917 |
| 120 | PRKACB | 0.36438862 |
| 121 | PRKCB | 0.34335140 |
| 122 | CAMK4 | 0.34277295 |
| 123 | MTOR | 0.33538550 |
| 124 | EGFR | 0.33031114 |
| 125 | PDK1 | 0.32239659 |
| 126 | CSNK1G2 | 0.31536139 |
| 127 | CSNK1A1 | 0.30237208 |
| 128 | STK16 | 0.30227115 |
| 129 | SGK223 | 0.30012399 |
| 130 | SGK494 | 0.30012399 |
| 131 | CSNK1G3 | 0.29440913 |
| 132 | MAP3K4 | 0.28061037 |
| 133 | MAP3K1 | 0.28040289 |
| 134 | LATS2 | 0.27868197 |
| 135 | BRSK1 | 0.27510878 |
| 136 | ITK | 0.26865030 |
| 137 | BRSK2 | 0.26006454 |
| 138 | NEK2 | 0.25960773 |
| 139 | PRKCA | 0.25912089 |
| 140 | IRAK2 | 0.25887374 |
| 141 | IRAK1 | 0.24193900 |
| 142 | MAP2K2 | 0.23266658 |
| 143 | ABL1 | 0.20830001 |
| 144 | PAK3 | 0.19917509 |
| 145 | CAMK1G | 0.19817426 |
| 146 | CSNK1A1L | 0.19811966 |
| 147 | PIK3CA | 0.19802623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.54563141 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.54978152 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40021901 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36321642 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08632334 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.77352452 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.71202167 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68676278 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62518887 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54502542 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48129193 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37470334 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25510713 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15518908 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14047072 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.08752210 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97593793 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95244202 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.94721849 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91072151 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90136397 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87346567 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80201438 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77764761 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75984479 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75919897 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74888521 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72091510 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70015737 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66090964 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61060055 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58332572 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56881472 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51994069 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51527800 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.49354483 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45330805 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35619513 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35256689 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34236967 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33478712 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27419822 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22671096 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20571473 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19040564 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.18322380 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16387260 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12087908 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03616864 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99652436 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98343270 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97647574 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96351416 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95885526 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93460213 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87093080 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84430248 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83592017 |
| 59 | Other glycan degradation_Homo sapiens_hsa00511 | 0.81698958 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.79902296 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75601934 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69683988 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66546506 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65300912 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58218370 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52526083 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46176649 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46020483 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40245865 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.38960810 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.36255295 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34762990 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.29867016 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.29013268 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25320522 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25102564 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24128863 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23190494 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.22452639 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21315137 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19115978 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15998684 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.13013940 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09579080 |
| 85 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.02833067 |
| 86 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01483102 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.00266217 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | -0.2515770 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2437051 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2432069 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2399066 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | -0.2390697 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2288587 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1978713 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1966342 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | -0.1821019 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1780216 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1624634 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1561812 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1552557 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1504895 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1378656 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1341888 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1267236 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1059344 |
| 106 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.1042154 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0858917 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0757430 |
| 109 | Protein export_Homo sapiens_hsa03060 | -0.0748733 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0684175 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0360302 |

